OptimizeRx Corporation

OPRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$20-$18-$11$0
Dep. & Amort.$4$2$2$2
Deferred Tax$1$0$0$0
Stock-Based Comp.$11$14$16$5
Change in WC$1-$16$4-$7
Other Non-Cash$7$10$0$0
Operating Cash Flow$5-$7$11$1
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0-$80-$2$0
Inv. Purchases$0-$163-$56$0
Inv. Sales/Matur.$0$219$0$0
Other Inv. Act.-$0-$1-$0-$0
Investing Cash Flow-$0-$25-$58-$0
Financing Activities
Debt Repay.-$4$36$0$0
Stock Issued$0$0$0$71
Stock Repurch.-$1-$8-$20$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0$1$3
Financing Cash Flow-$5$28-$19$74
Forex Effect$0$0$0$0
Net Chg. in Cash-$0-$4-$66$74
Supplemental Information
Beg. Cash$14$18$85$11
End Cash$13$14$18$85
Free Cash Flow$5-$8$10$0
OptimizeRx Corporation (OPRX) Financial Statements & Key Stats | AlphaPilot